Treating Woman with Myo-Inositol Vaginal Suppositories Improves Partner’s Sperm Motility and Fertility

Motility is the feature that allows spermatozoa to actively reach and penetrate the female gamete during fertilization. When this function is altered, and especially decreased, troubles in conceiving may occur. In this study, we demonstrated that treating fertile women with myo-inositol (MI) vaginal...

Full description

Saved in:
Bibliographic Details
Main Authors: Mario Montanino Oliva, Roberta Poverini, Rosella Lisi, Maria Cristina Carra, Franco Lisi
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2016/7621942
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832564763016560640
author Mario Montanino Oliva
Roberta Poverini
Rosella Lisi
Maria Cristina Carra
Franco Lisi
author_facet Mario Montanino Oliva
Roberta Poverini
Rosella Lisi
Maria Cristina Carra
Franco Lisi
author_sort Mario Montanino Oliva
collection DOAJ
description Motility is the feature that allows spermatozoa to actively reach and penetrate the female gamete during fertilization. When this function is altered, and especially decreased, troubles in conceiving may occur. In this study, we demonstrated that treating fertile women with myo-inositol (MI) vaginal suppositories ameliorated their partners’ sperm motility and also positively affected their conceiving capacity, without changes in cervical mucus structural and biochemical characteristics. Indeed, by means of the postcoital test on female cervical mucus, a significant improvement especially in progressive sperm motility was recorded after MI suppository use. Concomitantly, after MI treatment, a reduction of immotile spermatozoa percentage was observed. Importantly, MI vaginal supplementation positively correlated with a pregnancy for 5 of the 50 couples enrolled in the study, leading us to speculate that this substance may substantially contribute to create in the cervical mucus an ideal milieu that makes spermatozoa more motile and functionally able to fertilize. Even though the detailed mechanism is still unclear, these results should encourage MI vaginal use for the clinical improvement of male infertility, through their partners.
format Article
id doaj-art-88410691dd51436d869984c9b798f269
institution Kabale University
issn 1687-8337
1687-8345
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-88410691dd51436d869984c9b798f2692025-02-03T01:10:17ZengWileyInternational Journal of Endocrinology1687-83371687-83452016-01-01201610.1155/2016/76219427621942Treating Woman with Myo-Inositol Vaginal Suppositories Improves Partner’s Sperm Motility and FertilityMario Montanino Oliva0Roberta Poverini1Rosella Lisi2Maria Cristina Carra3Franco Lisi4Department of Obstetrics & Gynecology, Santo Spirito Hospital, 00100 Rome, ItalyIVF Unit, Villa Mafalda Clinic, 00100 Rome, ItalyIVF Unit, Villa Mafalda Clinic, 00100 Rome, ItalyIVF Unit, Villa Mafalda Clinic, 00100 Rome, ItalyIVF Unit, Villa Mafalda Clinic, 00100 Rome, ItalyMotility is the feature that allows spermatozoa to actively reach and penetrate the female gamete during fertilization. When this function is altered, and especially decreased, troubles in conceiving may occur. In this study, we demonstrated that treating fertile women with myo-inositol (MI) vaginal suppositories ameliorated their partners’ sperm motility and also positively affected their conceiving capacity, without changes in cervical mucus structural and biochemical characteristics. Indeed, by means of the postcoital test on female cervical mucus, a significant improvement especially in progressive sperm motility was recorded after MI suppository use. Concomitantly, after MI treatment, a reduction of immotile spermatozoa percentage was observed. Importantly, MI vaginal supplementation positively correlated with a pregnancy for 5 of the 50 couples enrolled in the study, leading us to speculate that this substance may substantially contribute to create in the cervical mucus an ideal milieu that makes spermatozoa more motile and functionally able to fertilize. Even though the detailed mechanism is still unclear, these results should encourage MI vaginal use for the clinical improvement of male infertility, through their partners.http://dx.doi.org/10.1155/2016/7621942
spellingShingle Mario Montanino Oliva
Roberta Poverini
Rosella Lisi
Maria Cristina Carra
Franco Lisi
Treating Woman with Myo-Inositol Vaginal Suppositories Improves Partner’s Sperm Motility and Fertility
International Journal of Endocrinology
title Treating Woman with Myo-Inositol Vaginal Suppositories Improves Partner’s Sperm Motility and Fertility
title_full Treating Woman with Myo-Inositol Vaginal Suppositories Improves Partner’s Sperm Motility and Fertility
title_fullStr Treating Woman with Myo-Inositol Vaginal Suppositories Improves Partner’s Sperm Motility and Fertility
title_full_unstemmed Treating Woman with Myo-Inositol Vaginal Suppositories Improves Partner’s Sperm Motility and Fertility
title_short Treating Woman with Myo-Inositol Vaginal Suppositories Improves Partner’s Sperm Motility and Fertility
title_sort treating woman with myo inositol vaginal suppositories improves partner s sperm motility and fertility
url http://dx.doi.org/10.1155/2016/7621942
work_keys_str_mv AT mariomontaninooliva treatingwomanwithmyoinositolvaginalsuppositoriesimprovespartnersspermmotilityandfertility
AT robertapoverini treatingwomanwithmyoinositolvaginalsuppositoriesimprovespartnersspermmotilityandfertility
AT rosellalisi treatingwomanwithmyoinositolvaginalsuppositoriesimprovespartnersspermmotilityandfertility
AT mariacristinacarra treatingwomanwithmyoinositolvaginalsuppositoriesimprovespartnersspermmotilityandfertility
AT francolisi treatingwomanwithmyoinositolvaginalsuppositoriesimprovespartnersspermmotilityandfertility